During the past decade, University Hospital Birmingham The Cancer Centre, Queen Elizabeth Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Birmingham The Cancer Centre, Queen Elizabeth Hospital" #1 collaborator was "Biocompatibles UK Ltd" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Birmingham The Cancer Centre, Queen Elizabeth Hospital" are "Bladder Cancer" (3 trials), "Advanced Solid Tumors" (1 trials), "Breast Cancer" (1 trials), "Colorectal Cancer Metastatic" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "University Hospital Birmingham The Cancer Centre, Queen Elizabeth Hospital" in a lesser frequency.

Most popular intervention types in "University Hospital Birmingham The Cancer Centre, Queen Elizabeth Hospital" are "Drug" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Abiraterone acetate" (1 trials), "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials), "CCS1477" (1 trials) and "Darolutamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Birmingham The Cancer Centre, Queen Elizabeth Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "University Hospital Birmingham The Cancer Centre, Queen Elizabeth Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in University Hospital Birmingham The Cancer Centre, Queen Elizabeth Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Birmingham The Cancer Centre, Queen Elizabeth Hospital, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".